Cognetivity Neurosciences Ltd.
CGN
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 18.39% | 44.65% | 44.59% | 45.74% | -10.30% |
| Total Depreciation and Amortization | -8.88% | -11.47% | -9.13% | -3.08% | 35.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 360.97% | -1.12% | -29.71% | -69.98% | -62.47% |
| Change in Net Operating Assets | -114.74% | -94.33% | -61.38% | -97.84% | 81.37% |
| Cash from Operations | 27.17% | 33.01% | 43.82% | -79.07% | -25.56% |
| Capital Expenditure | 99.74% | 101.47% | 93.14% | 61.86% | -12.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.55% | -121.10% | -196.98% | -7.46% | 155.69% |
| Cash from Investing | -121.46% | -204.69% | 18.07% | 33.46% | 132.82% |
| Total Debt Issued | -130.30% | -117.57% | -100.00% | -100.00% | -45.34% |
| Total Debt Repaid | -12.04% | 97.27% | 200.00% | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -100.00% | 28.64% | 35.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.48% | -26.27% | -23.42% | 99.69% | 112.36% |
| Foreign Exchange rate Adjustments | 400.00% | 168.75% | 82.35% | 33.33% | -119.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.00% | 104.23% | 143.71% | 7,416.47% | 2,125.25% |
